• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

100 例连续患者嗜酸性粒细胞增多的原因。

Causes of hypereosinophilia in 100 consecutive patients.

机构信息

Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Division of Hematology, University of the Philippines-Philippines General Hospital, Manila, Philippines.

出版信息

Eur J Haematol. 2020 Sep;105(3):292-301. doi: 10.1111/ejh.13437. Epub 2020 May 18.

DOI:10.1111/ejh.13437
PMID:32364630
Abstract

BACKGROUND

Hypereosinophilia (HE, persistent peripheral blood eosinophilia > 1.5 × 10 /L) and hypereosinophilic syndrome (HES, HE with end-organ damage) are classified as primary (due to a myeloid clone), secondary (due to a wide variety of reactive causes), or idiopathic. Diagnostic evaluation of eosinophilia is challenging, in part because secondary causes of HE/HES such as lymphocyte-variant HES (L-HES) and vasculitis are difficult to diagnose, and emerging causes such as immunoglobulin G4-related disease (IgG4-RD) have rarely been examined.

OBJECTIVE AND METHODS

We reviewed 100 consecutive patients with HE/HES who underwent extensive evaluation for primary and secondary eosinophilia at a single tertiary care center to determine causes of HE/HES in a modern context.

RESULTS

Six patients had primary HE/HES, 80 had a discrete secondary cause identified, and 14 had idiopathic HE/HES. The most common causes of secondary eosinophilia were L-HES/HES of unknown significance (L-HESus) (20), IgG4-RD (9), and eosinophilic granulomatosis with polyangiitis (EGPA) (8).

CONCLUSIONS

In contrast to other large published series of HE/HES, most patients in this study were found to have a discrete secondary cause of eosinophilia and only 14 were deemed idiopathic. These findings highlight the importance of extensive evaluation for secondary causes of eosinophilia such as L-HES, IgG4-RD, and EGPA.

摘要

背景

嗜酸性粒细胞增多症(HE,外周血嗜酸性粒细胞持续>1.5×10 /L)和嗜酸性粒细胞增多综合征(HES,HE 伴有终末器官损害)分为原发性(由于髓样克隆)、继发性(由于多种反应性原因)或特发性。嗜酸性粒细胞增多症的诊断评估具有挑战性,部分原因是淋巴细胞变异型 HES(L-HES)和血管炎等 HE/HES 的继发性原因难以诊断,而免疫球蛋白 G4 相关疾病(IgG4-RD)等新兴原因则很少被检查。

目的和方法

我们回顾了在一家三级保健中心接受广泛原发性和继发性嗜酸性粒细胞评估的 100 例连续 HE/HES 患者,以确定现代背景下 HE/HES 的病因。

结果

6 例患者为原发性 HE/HES,80 例患者确定了明确的继发性病因,14 例患者为特发性 HE/HES。继发性嗜酸性粒细胞增多症最常见的原因是未明确意义的 L-HES/HES(L-HESus)(20 例)、IgG4-RD(9 例)和嗜酸性肉芽肿伴多血管炎(EGPA)(8 例)。

结论

与其他发表的大型 HE/HES 系列研究相比,本研究中的大多数患者被发现有明确的继发性嗜酸性粒细胞增多症原因,只有 14 例被认为是特发性的。这些发现强调了对 L-HES、IgG4-RD 和 EGPA 等继发性嗜酸性粒细胞增多症进行广泛评估的重要性。

相似文献

1
Causes of hypereosinophilia in 100 consecutive patients.100 例连续患者嗜酸性粒细胞增多的原因。
Eur J Haematol. 2020 Sep;105(3):292-301. doi: 10.1111/ejh.13437. Epub 2020 May 18.
2
World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.世界卫生组织定义的嗜酸性粒细胞疾病:2014 年诊断、风险分层和管理更新。
Am J Hematol. 2014 Mar;89(3):325-37. doi: 10.1002/ajh.23664.
3
Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance.不明原因高嗜酸性粒细胞增多症患者的特征和临床结局。
Med Oncol. 2014 Jan;31(1):815. doi: 10.1007/s12032-013-0815-1. Epub 2013 Dec 14.
4
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.世界卫生组织定义的嗜酸性粒细胞疾病:2019 年诊断、风险分层和管理更新。
Am J Hematol. 2019 Oct;94(10):1149-1167. doi: 10.1002/ajh.25617.
5
World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.世界卫生组织定义的嗜酸性粒细胞疾病:诊断、风险分层和管理的 2022 年更新。
Am J Hematol. 2022 Jan 1;97(1):129-148. doi: 10.1002/ajh.26352. Epub 2021 Oct 8.
6
Marked and persistent eosinophilia in the absence of clinical manifestations.有明显且持续的嗜酸性粒细胞增多而无临床表现。
J Allergy Clin Immunol. 2014 Apr;133(4):1195-202. doi: 10.1016/j.jaci.2013.06.037. Epub 2013 Aug 26.
7
[Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis].[嗜酸性粒细胞增多症:高嗜酸性粒细胞综合征与嗜酸性肉芽肿性多血管炎]
Z Rheumatol. 2023 May;82(4):307-320. doi: 10.1007/s00393-023-01345-2. Epub 2023 Apr 26.
8
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.世界卫生组织和国际嗜酸性粒细胞疾病共识分类:2024 年关于诊断、风险分层和管理的更新。
Am J Hematol. 2024 May;99(5):946-968. doi: 10.1002/ajh.27287. Epub 2024 Mar 29.
9
IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series.IgG4相关性疾病与淋巴细胞变异型嗜酸性粒细胞增多综合征:一项对比病例系列研究。
Eur J Haematol. 2017 Apr;98(4):378-387. doi: 10.1111/ejh.12842. Epub 2017 Jan 20.
10
Advances in diagnosis and treatment of eosinophilia.嗜酸性粒细胞增多症的诊断与治疗进展
Curr Opin Hematol. 2009 Jan;16(1):3-8. doi: 10.1097/MOH.0b013e32831c841f.

引用本文的文献

1
The HL-60 clone 15 cell line as a model for leukocyte migration-possibilities and limitations.HL-60克隆15细胞系作为白细胞迁移模型的可能性与局限性。
Front Immunol. 2025 May 27;16:1515993. doi: 10.3389/fimmu.2025.1515993. eCollection 2025.
2
Lymphocytic Variant Hypereosinophilic Syndrome: Case Series From a Tertiary Referral Center in Canada.淋巴细胞变异型高嗜酸性粒细胞综合征:来自加拿大一家三级转诊中心的病例系列
EJHaem. 2025 Mar 29;6(2):e1109. doi: 10.1002/jha2.1109. eCollection 2025 Apr.
3
Head and Neck Classic Hodgkin, T and NK Lymphomas with Eosinophilia.
头颈部经典型霍奇金淋巴瘤、伴嗜酸性粒细胞增多的T和NK淋巴瘤。
Head Neck Pathol. 2025 Jan 28;19(1):10. doi: 10.1007/s12105-025-01751-9.
4
IgG4-related disease for the hematologist.血液科医生眼中的IgG4相关疾病。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):594-603. doi: 10.1182/hematology.2024000584.
5
When Blood Cell Counts Matter: Hypereosinophilic Syndrome as a Rare Cause of Ischemic Strokes.血细胞计数何时至关重要:高嗜酸性粒细胞综合征作为缺血性中风的罕见病因
Cureus. 2024 May 18;16(5):e60557. doi: 10.7759/cureus.60557. eCollection 2024 May.
6
Clinical Performance of Immunonephelometric Assay and Chemiluminescent Immunoassay for Detection of IgG Subclasses in Chinese.免疫比浊法和化学发光免疫分析法检测 IgG 亚类在中国的临床性能。
J Clin Lab Anal. 2024 Apr;38(8):e25033. doi: 10.1002/jcla.25033. Epub 2024 Apr 2.
7
The multidisciplinary approach to eosinophilia.嗜酸性粒细胞增多症的多学科治疗方法。
Front Oncol. 2023 May 18;13:1193730. doi: 10.3389/fonc.2023.1193730. eCollection 2023.
8
Characteristics of patients with incidental eosinophilia admitted to a tertiary hospital in southern China.中国南方一家三级医院收治的偶发性嗜酸性粒细胞增多症患者的特征。
Heliyon. 2023 Apr 20;9(5):e15569. doi: 10.1016/j.heliyon.2023.e15569. eCollection 2023 May.
9
Eosinophilia attention, diagnosis, treatment, and awareness in physicians: a cross-sectional survey.医生对嗜酸性粒细胞增多症的关注、诊断、治疗及认知:一项横断面调查
Ther Adv Chronic Dis. 2023 Jan 24;14:20406223221146938. doi: 10.1177/20406223221146938. eCollection 2023.
10
Eosinophilic airway diseases: basic science, clinical manifestations and future challenges.嗜酸性气道疾病:基础科学、临床表现及未来挑战
Eur Clin Respir J. 2022 Mar 2;9(1):2040707. doi: 10.1080/20018525.2022.2040707. eCollection 2022.